EQS Newsfeed
Corpare News, Press, Analysis
Made with ❤ von BGFL
#BGFLapp * beta
EQS News is by far the most important platform for official company news. Boersengefluester.de combines the latest ad-hoc announcements or other company news from our database, meaningful share charts and other useful links from the BGFL data pool, thus creating added value for investors who prefer to obtain timely and meaningful information from the original source. Tip: You are also welcome to use our newsfeed focussing on the latest analyst research to round things off.
25.04.2025 08:30PM
Confirms 2024 guidance and dividend, postpones publication for full-year results
Munich, April 25, 2025 – Nagarro SE has decided to postpone the publication of the 2024 full-year results and annual report as follows:
April 29, 2025: publication of preliminary 2024 results
May 15, 2025: publication of the audited 2024 financial statements and 2024 annual report
This additional time is needed to complete the preparation and th [ … ]
25.04.2025 01:36PM
Accentro Real Estate AG begins with the implementation of the restructuring solution
Accentro Real Estate AG begins with the implementation of the restructuring solution
Berlin, 25 April 2025 – Following the agreement in principle reached on 29 March 2025 on a comprehensive restructuring solution, the Management Board with the approval of the Supervisory Board has today decided to begin implementing the restructuring solution.
Th [ … ]
25.04.2025 08:46AM
Q1 earnings significantly below market expectations, full-year forecast confirmed
Bechtle AG: Q1 earnings significantly below market expectations, full-year forecast confirmed
Neckarsulm, 25 April 2025 – In the first quarter of 2025, Bechtle AG continued to face the impact of challenging economic conditions. As expected by Bechtle, preliminary figures show a significant year-on-year decline in first-quarter earnings before t [ … ]
25.04.2025 07:00AM
BB Biotech AG publishes its interim report
Ad hoc announcement pursuant to Art. 53 LR
April 25, 2025
BB Biotech AG publishes its interim report
BB Biotech AG (ISIN CH0038389992) today published its interim report as at March 31, 2025, which covers the results of its business activities for the first three months of 2025.
Based on the consolidated accounts of BB Biotech AG, net loss for [ … ]
24.04.2025 10:45PM
Merck confirms late-stage discussions with SpringWorks Therapeutics, Inc. on potential acquisition
Darmstadt, April 24, 2025 – Merck KGaA (“Merck”) reacts to press reports and confirms late-stage discussions with SpringWorks Therapeutics, Inc. on a potential acquisition. The parties are in discussion on the basis of a price of around USD 47 per share. Merck notes that no final decision has been taken and no legally binding agreement has been ent [ … ]
Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
